At 2 years following transcatheter aortic valve replacement, nonagenarians experienced no greater risk for mortality or stroke than younger patients, despite being at greater surgical risk, researchers reported. However, nonagenarians had greater prevalence of HF readmission than younger patients, according to the researchers.
|